NetworkNewsBreaks – Delic Holdings Corp. (CSE: D
Post# of 135

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has reported that, further to its news release dated May 16, 2022, the company has filed its annual financial statements, management’s discussion and analysis, and related certifications for the year ended Dec. 31, 2021, (collectively, the “annual filings”). Delic expects that the management cease trade order (the “MCTO”), which was issued on May 3, 2022, will be revoked in the coming days. While the MCTO remains in effect, the general investing public will continue to be able to trade Delic’s securities. However, for the duration of the MCTO, Delic’s chief executive officer and chief financial officer are precluded from trading in the securities of the company.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

